PreprintCited by 71Neuroinflammation and Neurodegeneration MechanismsAdvanced Proteomics Techniques and ApplicationsAlzheimer's disease research and treatments

Flow-cytometric microglial sorting coupled with quantitative proteomics identifies moesin as a highly-abundant microglial protein with relevance to Alzheimer’s disease

Open access
Rayaprolu, Sruti, Gao, Tianwen, Xiao, Hailian, Ramesha, Supriya, Weinstock, Laura D., Shah, Jheel, Duong, Duc M., Dammer, Eric B. +7 more·2019·Molecular Neurodegeneration

Preprint — published as 10.1186/s13024-020-00377-5 · Paper page

Abstract

Background: Proteomic characterization of microglia provides the most proximate assessment of functionally relevant molecular mechanisms of neuroinflammation. However, microglial proteomics studies have been limited by low cellular yield and contamination by non-microglial proteins using existing enrichment strategies. Methods: We coupled magnetic-activated cell sorting (MACS) and fluorescence activated cell sorting (FACS) of microglia with tandem mass tag-mass spectrometry (TMT-MS) to obtain a highly-pure microglial proteome and identified a core set of highly-abundant microglial proteins in adult mouse brain. We interrogated existing human proteomic data for Alzheimer’s disease (AD) relevance of highly-abundant microglial proteins and performed immuno-histochemical and in-vitro validation studies. Results: Quantitative multiplexed proteomics by TMT-MS of CD11b+ MACS-enriched ( N = 5 mice) and FACS-isolated ( N = 5 mice), from adult wild-type mice, identified 1,791 proteins. A total of 203 proteins were highly abundant in both datasets, representing a core-set of highly abundant microglial proteins. In addition, we found 953 differentially enriched proteins comparing MACS and FACS-based approaches, indicating significant differences between both strategies. The FACS-isolated microglia proteome was enriched with cytosolic, endoplasmic reticulum, and ribosomal proteins involved in protein metabolism and immune system functions, as well as an abundance of canonical microglial proteins. Conversely, the MACS-enriched microglia proteome was enriched with mitochondrial and synaptic proteins and higher abundance of neuronal, oligodendrocytic and astrocytic proteins. From the 203 consensus microglial proteins with high abundance in both datasets, we confirmed microglial expression of moesin (Msn) in wild-type and 5xFAD mouse brains as well as in human AD brains. Msn expression is nearly exclusively found in microglia that surround Aβ plaques in 5xFAD brains. In in-vitro primary microglial studies, Msn silencing by siRNA decreased Aβ phagocytosis and increased lipopolysaccharide-induced production of the pro-inflammatory cytokine, tumor necrosis factor (TNF). In network analysis of human brain proteomic data, Msn was a hub protein of an inflammatory co-expression module positively associated with AD neuropathological features and cognitive dysfunction. Conclusions: Using FACS coupled with TMT-MS as the method of choice for microglial proteomics, we define a core set of highly-abundant adult microglial proteins. Among these, we validate Msn as highly-abundant in plaque-associated microglia with relevance to human AD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/802694

Cites

76 of 76 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [39]Chen MJ, Ramesha S, Weinstock LD, Gao T, Ping L, Xiao H, Dammer EB, Duong DD, Levey AI, Lah JJ, et al. Microglial ERK signaling is a critical regulator of pro-inflammatory immune responses in Alzheimer’s disease. bioRxiv. 2019:798215.

Cited by

Sorted by citations

Authors
Rayaprolu, S., Gao, T., Xiao, H., Ramesha, S., Weinstock, L. D., Shah, J., Duong, D. M., Dammer, E. B., Webster, J. A., Lah, J. J., Wood, L. B., Betarbet, R., Levey, A. I., Seyfried, N. T., & Rangaraju, S.
Affiliations
  • Emory University (US)
  • Central South University (CN)
  • Georgia Institute of Technology (US)
Corresponding author
  • Seyfried, Nicholas T.
  • Rangaraju, Srikant
Venue
Molecular Neurodegeneration
Publisher
openRxiv
Published
2019-10-17
Volume
15
Issue
1
Pages
28-28
ISSN
1750-1326 (ISSN-L)
OpenAlex
W3021043548
Cited by
71
References
76
Citations by year
2026: 6 · 2025: 14 · 2024: 8 · 2023: 14 · 2022: 21 · 2021: 5 · 2020: 3
FWCI
4.55
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Molecular Neurodegeneration (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Alzheimer's Association (P50 AG025688, 37102, 11060)
  • Georgia Institute of Technology
  • Emory University (R01AG061800, RF1AG057471, UL1 TR002378, R01AG053960, P50AG025688, U01AG061357, AG025688, RF1AG057470)
  • National Institutes of Health (K08‐NS099474‐1, AG025688, NS099474-1, UL1TR002378)
  • Alzheimer's Disease Research Center, Emory University (P50 AG025688, AG025688)
  • School of Medicine, Emory University (UL1-TR002378)
  • National Institute on Aging (AG 025688, RF1AG057470, R01AG057911, R01AG057739, U01AG061357, RF1AG062181, U01AG046161, F32AG064862, RF1AG057330, RF1AG057471, P50AG025688, R21AG056781, R01AG053960, R01AG061800)
  • National Institute of General Medical Sciences (T32GM008433)
  • National Institute of Neurological Disorders and Stroke (K08-NS099474-1, K08NS099474, R01NS114130, P30NS055077)
  • National Center for Advancing Translational Sciences
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
Keywords
moesin, microglia, Alzheimer's disease, magnetic cell separation, fluorescence-activated cell sorting, amyloid plaques, amyloid-beta phagocytosis, neuroinflammation, TNF-α, 5xFAD mice, hub proteins, co-expression network
MeSH terms
Alzheimer Disease, Animals, Brain, Disease Models, Animal, Endoplasmic Reticulum, Flow Cytometry, Humans, Macrophages, Microfilament Proteins, Microglia, Proteomics, Mice, Cognitive Dysfunction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review